Stock Symbol:

LCI

Company Name:

Lannett Company, Inc.

Company Description:

Lannett Company, Inc. develops, manufactures, markets, and distributes generic versions of pharmaceutical products in the United States. The company manufactures and/or sells various prescription products. Its product portfolio includes acetazolamide, baclofen, and bethanechol chloride tablets; amantadine gel capsules; butalbital, aspirin, and caffeine with codeine phosphate, danazol, and clindamycin HCl capsules; cocaine topical solution; and dicyclomine tablets and capsules.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

J-A-J-O

Stock Exchange:

AMEX

Predicted Split Price:

$149.00

Predicted Split Ratio:

3 for 2

5 Day Performance After Split:

1.8%

Prior Stock Splits:

1

Stock Split History:

03-Mar-03 [3:2]

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.